Details
Stereochemistry | RACEMIC |
Molecular Formula | 2C10H13N3O2.H2O4S |
Molecular Weight | 512.537 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OS(O)(=O)=O.NC(=N)NCC1COC2=C(O1)C=CC=C2.NC(=N)NCC3COC4=C(O3)C=CC=C4
InChI
InChIKey=NSGHAKPGHCNTPS-UHFFFAOYSA-N
InChI=1S/2C10H13N3O2.H2O4S/c2*11-10(12)13-5-7-6-14-8-3-1-2-4-9(8)15-7;1-5(2,3)4/h2*1-4,7H,5-6H2,(H4,11,12,13);(H2,1,2,3,4)
Molecular Formula | H2O4S |
Molecular Weight | 98.078 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C10H13N3O2 |
Molecular Weight | 207.2291 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14147778
The drug may be given orally initially
at a dose of 20 mg. daily and doubled every fourth day until an effect is obtained. Where more rapid effect is desired, a loading dose of 40 mg. may be used.
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:19 GMT 2023
by
admin
on
Fri Dec 15 15:04:19 GMT 2023
|
Record UNII |
N6IT80R85G
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000086696
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY | |||
|
m5873
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY | Merck Index | ||
|
N6IT80R85G
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY | |||
|
SUB02432MIG
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY | |||
|
C174743
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY | |||
|
108162
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL76725
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY | |||
|
23724918
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY | |||
|
DBSALT002676
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY | |||
|
5714-04-5
Created by
admin on Fri Dec 15 15:04:19 GMT 2023 , Edited by admin on Fri Dec 15 15:04:19 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |